ロード中...
Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma
BACKGROUND: Esophageal cancer remains one of the hardest cancers to treat with rising incidence rates, low overall survival and high levels of treatment resistance. The lack of clinically available biomarkers hinder diagnosis and treatment stratification. While large scale sequencing approaches have...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6136712/ https://ncbi.nlm.nih.gov/pubmed/30212533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0203173 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|